GJA1 and cancer: Because tumors are heterogeneous, in the context of Cx43, resistance could arise through a selection of cells that harbor reduced Cx43 expression levels, potentially including cancer stem cells as has been described in various tumor types including gliomas which could contribute to a more aggressive, cisplatin-resistant phenotype [38].